Dolly the Sheep Marks 30 Years as First Mammal Cloned From Adult DNA

Q: If a clone can't replicate personality, what are grieving pet owners truly buying?

They are buying a genetically identical new animal and, more than that, a form of emotional continuity — not the return of the pet they lost. Dolly’s legacy proved that DNA from an adult cell can be used to create a genetic copy. Commercial pet-cloning firms now sell that same promise to bereaved owners: a cat, dog or horse with the same genome as the original. That can increase the chance of similar physical traits and some inherited tendencies. But experts are clear that DNA is not personality. Behavior is shaped by environment, upbringing, training, chance experiences and the bond formed with a particular owner over time. Even appearance may vary, because gene expression can differ. A clone is better understood as a genetic twin born later, not a resurrection. What owners are often paying for, then, is symbolic value. The clone can serve as a living connection to the lost animal, a way to preserve part of its biological identity and soften grief. For some, that offers comfort, hope and a sense that the relationship has not ended completely. That emotional appeal helps explain why pet cloning has become a niche business despite high costs and scientific limits. The ethical tension is that the service can be marketed close to the language of replacement, when the reality is different: owners receive a new animal with a powerful genetic link to the old one, but its own distinct life, temperament and bond.

2 articles · Updated · Metro.co.uk · Jul 5

Born on July 5, 1996 at the Roslin Institute, Dolly became the first mammal cloned from adult DNA, a milestone now being marked 30 years later.
One mammary gland cell from a Finn Dorset sheep let researchers prove an adult somatic cell could generate a genetically identical animal, overturning the belief that only embryonic cells could do so.
Her unveiling in 1997 triggered global scientific and ethical debate, including fears over human cloning, though Roslin said its aim was disease research rather than creating human clones.
Dolly’s legacy extended into stem-cell science: Shinya Yamanaka later said her case helped inspire induced pluripotent stem cell research, which won the 2012 Nobel Prize.
Dolly died in 2003 aged 6 after a lung infection and remains a major exhibit at Scotland’s National Museum, while animal cloning has since spread into livestock, racing horses and $50,000 pet cloning.